208 related articles for article (PubMed ID: 24296579)
1. Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics.
Khoruts A
Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):79-80. PubMed ID: 24296579
[TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea.
Cohen NA; Ben Ami R; Guzner-Gur H; Santo ME; Halpern Z; Maharshak N
Isr Med Assoc J; 2015 Aug; 17(8):510-4. PubMed ID: 26394495
[TBL] [Abstract][Full Text] [Related]
3. Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile.
Ley RE
Nat Med; 2014 Mar; 20(3):248-9. PubMed ID: 24603797
[No Abstract] [Full Text] [Related]
4. Faecal microbiota transplantation.
Nieuwdorp M
Br J Surg; 2014 Jul; 101(8):887-8. PubMed ID: 24844698
[No Abstract] [Full Text] [Related]
5. Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease.
Russell GH; Kaplan JL; Youngster I; Baril-Dore M; Schindelar L; Hohmann E; Winter HS
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):588-92. PubMed ID: 24792627
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities for faecal microbiota transplantation therapy.
Rogers GB; Bruce KD
Epidemiol Infect; 2013 Nov; 141(11):2235-42. PubMed ID: 23735045
[TBL] [Abstract][Full Text] [Related]
7. Review article: faecal transplantation therapy for gastrointestinal disease.
Landy J; Al-Hassi HO; McLaughlin SD; Walker AW; Ciclitira PJ; Nicholls RJ; Clark SK; Hart AL
Aliment Pharmacol Ther; 2011 Aug; 34(4):409-15. PubMed ID: 21682755
[TBL] [Abstract][Full Text] [Related]
8. New perspectives in Clostridium difficile disease pathogenesis.
Monaghan TM
Infect Dis Clin North Am; 2015 Mar; 29(1):1-11. PubMed ID: 25573674
[TBL] [Abstract][Full Text] [Related]
9. Beneficial modulation of the gut microbiota.
Walsh CJ; Guinane CM; O'Toole PW; Cotter PD
FEBS Lett; 2014 Nov; 588(22):4120-30. PubMed ID: 24681100
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation for recurrent clostridium difficile infection.
Brandt LJ; Reddy SS
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S159-67. PubMed ID: 21992957
[TBL] [Abstract][Full Text] [Related]
11. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection.
Brandt LJ
Am J Gastroenterol; 2013 Feb; 108(2):177-85. PubMed ID: 23318479
[TBL] [Abstract][Full Text] [Related]
12. [Recurrent Clostridium difficile infections: the importance of the intestinal microbiota].
Zanella Terrier MC; Frossard JL; Simonet ML
Rev Med Suisse; 2013 Oct; 9(402):1898, 1900-4. PubMed ID: 24298714
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for recurrent C difficile infection: ready for prime time?
Agito MD; Atreja A; Rizk MK
Cleve Clin J Med; 2013 Feb; 80(2):101-8. PubMed ID: 23376915
[TBL] [Abstract][Full Text] [Related]
14. Development of fecal microbiota transplantation suitable for mainstream medicine.
Khoruts A; Sadowsky MJ; Hamilton MJ
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation-early steps on a long journey ahead.
Khoruts A
Gut Microbes; 2017 May; 8(3):199-204. PubMed ID: 28394706
[No Abstract] [Full Text] [Related]
17. Moving fecal microbiota transplantation into the mainstream.
Orenstein R; Griesbach CL; DiBaise JK
Nutr Clin Pract; 2013 Oct; 28(5):589-98. PubMed ID: 23979974
[TBL] [Abstract][Full Text] [Related]
18. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications.
Collins SM; Kassam Z; Bercik P
Curr Opin Microbiol; 2013 Jun; 16(3):240-5. PubMed ID: 23845749
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
Gens KD; Elshaboury RH; Holt JS
J Pharm Pract; 2013 Oct; 26(5):498-505. PubMed ID: 23966282
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
Baines SD; Noel AR; Huscroft GS; Todhunter SL; O'Connor R; Hobbs JK; Freeman J; Lovering AM; Wilcox MH
J Antimicrob Chemother; 2011 Jul; 66(7):1537-46. PubMed ID: 21504940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
